DSP Global Innovation Overseas Equity Omni FoF Regular-Growth
Equity: InternationalVery High Risk
PaisaSmart ratingNot rated yet
Why this rating
This fund is not currently rated by our system. However, we continuously review and update our ratings, so it may be included in the future.
Our score weighs long-term performance, risk and consistency — not just past returns.
Returns
As of 6 Oct 2026
1W
+3.69%
1M
+6.42%
3M
+5.56%
6M
+29.54%
9M
+20.47%
1Y
+24.09%
2Y
+25.75%
3Y
+29.86%
4Y
+29.61%
Since launch
+19.86%
Risk ratios
As of 30 Sep 2026
Standard deviation
16.46
Sharpe ratio
1.28
Sortino ratio
2.71
Mean
26.65
Portfolio
As of 31 Aug 2026
Holdings (7)
| Holding | % of fund | Value | Shares |
|---|---|---|---|
| BlueBox Global Technology Fund : Share Class I (USD) Acc | 40.20% | ₹581.77 Cr | 20,194 |
| iShares NASDAQ 100 UCITS ETF USD | 28.14% | ₹407.29 Cr | 25,003 |
| Invesco NASDAQ-100 Equal Weight UCITS ETF Acc | 12.53% | ₹181.42 Cr | 22,78,381 |
| KraneShares CSI China Internet UCITS ETF USD | 9.34% | ₹135.18 Cr | 7,10,223 |
| Fidelity Select Medical Technology And Devices | 3.75% | ₹54.3 Cr | 1,07,280 |
| BlueBox Precision Medicine Fund : Share Class D (USD) Acc Forgn.MF- Equity | 2.50% | ₹36.21 Cr | 2,405 |
| Others | -0.17% | ₹-2.61 Cr | — |
Fund details
In brief
Long-term capital growth. Investments in units of overseas funds which invest in equity and equity related securities of companies which are forefront in innovation.
Investment objective
The scheme seeks capital appreciation by investing in global mutual funds schemes and ETFs that primarily invest in companies with innovation theme having potential for higher revenue and earnings growth.
Fund type
Open-ended
Min lumpsum
₹100
Min withdrawal
₹1
Lock-in
None
SIP
Available
SWP
Available
STP
Available
Purchase cut-off
15:00